Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant < em > Acinetobacter baumannii < /em > Infections
CONCLUSIONS: SUL-DUR has shown to be predominantly noninferior to alternative antibiotics in the treatment of pneumonias caused by CRAB, making it a viable treatment option. Further postmarketing data is needed to ascertain its role in other infections.PMID:37817550 | DOI:10.1177/10600280231204566
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Benjamin August Andrew Matlob Pramodini B Kale-Pradhan Source Type: research
More News: Acinetobacter | Clinical Trials | Databases & Libraries | Drugs & Pharmacology | Kale | Microbiology | Pneumonia | Study